文献速递产科母胎医学

在美国人群中应用胎儿医学基金会竞争风险模型进行早孕期联合筛查预测早产子痫前期

Performance of a first-trimester combined screening for preterm preeclampsia in the United States population using the fetal medicine foundation competing risks model.
PubMed 文献 · Am J Obstet Gynecol MFM · 2025-09-29

本研究为回顾性队列研究,纳入8664例初产妇,其中189例(2.2%)发生早产子痫前期。胎儿医学基金会(FMF)早孕期联合筛查模型的AUC为0.75(95% CI 0.71-0.78),区分能力中等;校准图显示模型低估风险,再校准后改善;决策曲线分析显示在常用阈值(1%-12%)范围内有净临床获益。

要点

  • FMF早孕期联合筛查模型预测早产子痫前期的AUC为0.75(95% CI 0.71-0.78),区分能力中等。
  • 采用0.7%切点时,灵敏度64.0%、特异度72.5%、阳性预测值4.9%、阴性预测值98.9%。
  • 校准图显示模型低估风险,再校准后改善;决策曲线分析支持临床效用,提示需人群特异性调整。

核心结论

  • FMF早孕期筛查算法表现出中等预测性能,再校准可改善风险估计,决策曲线分析支持临床效用,并强调需进行人群特异性调整。

研究设计与样本

  • 回顾性队列研究,使用Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be(nuMoM2b)数据,排除20周前分娩、结局数据缺失或使用阿司匹林者,最终纳入8664例初产妇。
  • FMF模型纳入母体因素、平均动脉压、胎盘生长因子、妊娠相关血浆蛋白A及子宫动脉搏动指数(由中孕期值校正)。

主要发现

  • 8664例初产妇中189例(2.2%)发生早产子痫前期。
  • FMF模型AUC为0.75(95% CI 0.71-0.78),区分能力中等。
  • 采用0.7%切点时,灵敏度64.0%、特异度72.5%、阳性预测值4.9%、阴性预测值98.9%,阳性似然比2.3、阴性似然比0.5、OR 4.7。
  • 校准图显示模型低估风险,再校准后对齐改善;决策曲线分析显示在常用阈值(1%-12%)范围内有净临床获益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia complicates 2% to 8% of pregnancies and is a leading cause of maternal and perinatal morbidity and mortality. In the United States, current guidelines recommend low-dose aspirin based on clinical risk factors, which identify only a minority of those at risk for preterm preeclampsia. The Fetal Medicine Foundation (FMF) competing risks algorithm improves prediction by combining maternal characteristics, biophysical parameters, and biochemical markers. While validated internationally, its performance in the U.S. population remains unclear. OBJECTIVE: To evaluate the performance of the FMF first-trimester combined screening algorithm for predicting preterm preeclampsia in a diverse U.S. nulliparous population. STUDY DESIGN: We performed a retrospective cohort study using data from the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b). We excluded those with delivery before 20 weeks, missing outcome data, or aspirin use. The FMF model incorporated maternal factors, mean arterial pressure, placental growth factor, pregnancy-associated plasma protein-A, and uterine artery pulsatility index (adjusted from second-trimester values). The primary outcome was preterm preeclampsia, defined as preeclampsia requiring delivery <37 weeks. Model performance was assessed via area under the receiver-operating characteristics curve (AUROC) with 95% confidence interval (CI), with optimal cut-off determined using Liu's method. Sensitivity, specificity, positive and negative predictive values (PPV and NPV), likelihood ratios (LHR), and odds ratios (OR) were calculated using the optimal cut-off. Goodness of fit was evaluated using a calibration plot and decision curve analysis. RESULTS: Of 8,664 nulliparous individuals, 189 (2.2%) had preterm preeclampsia. The FMF model revealed an AUC of 0.75 (95% CI 0.71-0.78), indicating moderate discriminative ability. Using a 0.7% cut-off, sensitivity was 64.0%, specificity 72.5%, PPV 4.9%, and NPV 98.9%. Positive LHR was 2.3, negative LHR 0.5, and OR 4.7. The calibration plot showed the model underestimated risk, while recalibration improved alignment. Decision curve analysis demonstrated net clinical benefit across commonly used thresholds (1%-12%). CONCLUSION: The FMF first-trimester screening algorithm demonstrated moderate predictive performance. Recalibration enhanced risk estimation, and decision curve analysis supported clinical utility, highlighting the need for population-specific adjustment. El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Martins JG, Miller E, Aboukhater D, et al. Performance of a first-trimester combined screening for preterm preeclampsia in the United States population using the fetal medicine foundation competing risks model. Am J Obstet Gynecol MFM. 2025. PMID: 41033489. doi:10.1016/j.ajogmf.2025.101803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。